Letter to the editor: Deep learning and digital pathology for HCC prediction in steatotic liver disease [0.03%]
读者来信：用于脂肪性肝病中肝癌预测的深度学习与数字病理学
Luisa Giudice,Stefano Granieri,Stefania Galassi et al.
Luisa Giudice et al.
Reply: From weight to waist: Refining fibrosis prediction in the global MASLD cohort [0.03%]
关于从体重到腰围：在全世界MASLD队列中精炼纤维化预测的来信答复
Maria Stepanova,Zobair M Younossi
Maria Stepanova
Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease [0.03%]
与Fontan肝病患者肝细胞癌的基因组和转录组谱分析
Taiji Yamazoe,Eiji Kakazu,Michitaka Matsuda et al.
Taiji Yamazoe et al.
Background aims: Fontan-associated liver disease (FALD) could lead to liver cirrhosis and hepatocellular carcinoma (HCC). The prognosis of FALD patients is worse when HCC develops. Therefore, better understanding of the m...
Stroma-driven inter- and intratumoral heterogeneity of PD-L1 expression in cholangiocarcinoma: Implications for biomarker development and prognostic evaluation [0.03%]
胆管癌中由肿瘤间质介导的PD-L1表达异质性：生物标志物开发和预后评估的意义
Anna Saborowski,Simon Peters,Jinbo Zhao et al.
Anna Saborowski et al.
Background and aims: Immune checkpoint inhibitors are now considered as part of standard of care in biliary tract cancer, based on a statistically significant but overall modest survival benefit in recent pivotal trials. ...
Alcohol use dominates determining liver related events in steatotic liver disease: Rethinking the role of metabolic dysfunction [0.03%]
酒精使用在肝脂肪性疾病中占主导地位：重新思考代谢功能障碍的作用
Luis Antonio Díaz,Winston Dunn,Ashwani K Singal
Luis Antonio Díaz
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma [0.03%]
NRF2-COX2-PGE2轴驱动免疫冷肿瘤并预测肝细胞癌联合免疫治疗耐药性
Shuhei Yamamoto,Takahiro Kodama,Akifumi Kuwano et al.
Shuhei Yamamoto et al.
Background aims: Atezolizumab plus bevacizumab (Atez/Bev) is the first-line immunotherapy for advanced hepatocellular carcinoma (HCC), yet many patients show primary or acquired resistance. We aimed to identify tumor-intr...
Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma [0.03%]
一种可解释的多模态模型用于预测肝癌局部肿瘤进展和肿瘤侵袭性大小
Wenzhen Ding,Jiapeng Wu,Jianping Dou et al.
Wenzhen Ding et al.
Purpose: Local tumor progression (LTP) of hepatocellular carcinoma (HCC) after thermal ablation (TA) is related to tumor invasiveness and threaten the health. We aim to build a multimodal model to explicable tumor invasiv...
Pedro Ochoa-Allemant,Marina Serper
Pedro Ochoa-Allemant
Fellows' Corner [0.03%]
驻院学者小筑
Maya Deeb
Maya Deeb